Roles of oxidative stress in Xeroderma Pigmentosum

Advances in Experimental Medicine and Biology

Volumn 637, Issue , 2008, Pages 120-127

  Hayashi, Masaharu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FREE RADICAL; NUCLEOTIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

AUTOPSY; BASAL GANGLION; BRAIN; BRAIN DAMAGE; CELL DAMAGE; CEREBELLUM DEGENERATION; CEREBROSPINAL FLUID; COCKAYNE SYNDROME; DEGENERATIVE DISEASE; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCISION REPAIR; GLOBUS PALLIDUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; TRICHOTHIODYSTROPHY; URINE; XERODERMA PIGMENTOSUM; DNA REPAIR; METABOLISM; PATHOLOGY;

DNA DAMAGE; DNA REPAIR; HUMANS; OXIDATIVE STRESS; XERODERMA PIGMENTOSUM;

EID: 60549092906     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09599-8_13     Document Type: Review

References (40)

1. Halliwell B. Oxidative stress and neurodegeneration: where arc we know? J Neurochem 2006; 97(6): 1634-1658.
2. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64:97-112.
3. Dalle-Donne I, Rossi R, Colombo R ct al. Biomarkers of oxidative damage in human disease. CUn Chem 2006; 52(4):601-623.
4. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology Pathol Int 1999; 49(2):91-102.
5. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hy-droxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-indeuccd renal carcinogenesis model. Lab Invest 1997; 76(3):365-374.
6. Viassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 1994; 70(2): 138-151.
7. Laposa RR, Cleaver JE. DNA repair on the brain. Proc Nad Acad Sci USA 2001; 98(23):12860-12862.
8. Nishigori C, Hattori Y, Toyokuni S. Role of reactive species in skin carcinogenesis. Antioxid Redox Signal 2004; 6(3):561-570.
9. Reardon JT, Bessho T, Kung H C et al. In vitro repair of oxidative DNA damage by human nuclotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Nad Acad Sci USA 1997; 94(17):9463-9468.
10. Le Page F, Kwoh EE, Avrutskaya A et al. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH and CSB and implication for Cockayne syndrome. Cell 2000; 101(2):159-171.
11. Balajee AS, Dianova I, Bohr VA. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B-cells. Nucleic Acids Res 1999; 27(22):4476-4482.
12. Tuo J, Jaruga P, Rodrigue H et al. Primary fibroblast of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine residting from oxidative stress. FASEB J 2003; 17(6):668-674.
13. Arbault S, Sojic N, Bruce D et al. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 2004; 25(4):509-515.
14. Brooks PJ, Wise DS, Berry DA et al. The oxidative DNA lesion 8, 5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J Biol Chem 2000; 275(29):22355-22362.
15. de Waard H, de Wit J, Gorgcls TG et al. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA repair 2003; 2(l):13-25.
16. Schallreuter KU, Pittelkow MR, Wood JM. Defects in antioxidant defense and calcium transport in the epidermis of xeroderma pigmentosum patients. Arch Dermatol Res 1991; 283(7) :449-455.
17. Vuillaume M, Daya-Grosjcan L, Vincens P et al. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 1992; 13(3):321-328.
18. Hoffschir F, Daya-Grosjean L, Petit PX et al. Low catalase activity in xeroderma pigmentosum fibroblasts and SV40-transformed human cell lines is directly related to decreased intracellular levels of the cofactor, NADPH. Free Radic Biol Med 1998; 24(5):809-816.
19. Zecca 1, Youdim MB, Riederer P et al. Iron, brain ageing and neurodegenerative disorders. Nat Review Neurosci 2004; 5(ll):863-873.
20. Simonian NA, Coylc JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83-116.
21. Nunomura A, Castellani RJ, Zhu X et al. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006; 65(7):631-641.
22. Jenner P. Oxidative stress in Parkinsons disease. Ann Neurol 2003; 53(suppl 3):S26-S38.
23. Liu J, Lillo C, Jonsson PA et al. Toxicity of familial ALS-linked SODl mutants from selective recruitment of spinal mitochondria. Neuron 2004; 43(1):5-17.
24. Nunomura A, Perry G, Pappolla MA et al. Neuronal oxidative stress precedes amyloid-P deposition in Down syndrome. J Neuropathol Exp Neurol 2000; 59(11):1011-1017.
25. Haynes RL, Baud O, Li J et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Padiol 2005; 15(3):225-233.
26. Hayashi M, Aral N, Satoh J ct al. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol 2002; 17(10):725-730.
27. Hayashi M, Araki S, Arai N ct al. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain Dev 2002; 24(8)-.770-775.
28. Araki S, Hayashi M, Tamagawa K et al. Neuropathological analysis in spinal muscular atrophy type II. Acta Neuropathol 2003; 106(5):44l-448.
29. Hachiya Y, Hayashi M, Kiunada S et al. Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinosis. Acta Neuropathol 2006; HI(2): 168-177.
30. Anzai Y, Hayashi M, Fueki N et al. Protracted juvenile neuronal ceroid lipofuscinosisan autopsy report and immunohistochemical analysis. Brain Dev 2006; 28(7):462-465.
31. Bootsma D, Kraemer KH, Cleaver JE et al. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. In: Scriber CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. Vol. I, New York: McGraw-Hill, Inc., 2001:677-703.
32. Itoh M, Hayashi M, Shioda K et al. Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev 1999; 21(5):326-333.
33. Kohji T, Hayashi M, Shioda K et al. Cerebellar neurodegeneration in human hereditary DNA repair disorders. Neurosci Lett 1998; 243(1-3):133-136.
34. Hayashi M, Itoh M, Araki S et al. Oxidative stress and glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol 2001; 60(4):350-356.
35. Hayashi M, Araki S, Kohyama J et al. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev 2005; 27(l):34-38.
36. Hayashi M, Araki S, Kohyama J et al. Brainstem and basal ganglia lesions in xeroderma pigmentosum group A. J Neuropathol Exp Neurol 2004; 63(10): 1048-1057.
37. Matsubasa T, Uchino T, Karashima S et al. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002; 36(2):189-193.
38. Tsukahara H, Haruta T, Ono N et al. Oxidative stress in childhood meningitis: measurement of 8-hydroxy-2'-deoxyguanosine concentration in cerebrospinal fluid. Redox Rep 2000; 5(5):295-298.
39. Tsukahara H, Haruta T, Todoroki Y et al. Oxidant and antioxidant activities in childhood meningitis. Life Sci 2002; 71(23):2797-2806.
40. Schulpis KH, Lazaropoulou C, Regoutas S et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicology 2006; 217(2-3):228-232.